1.
Babiarczyk B, Haratyk A, Guzak B. Quality of life of patients with diabeticretinopathy receiving anti-VEGF therapy. Piel21w [Internet]. 2025 Sep. 24 [cited 2025 Dec. 8];24(3(92):241-9. Available from: https://czasopisma.umlub.pl/piel21w/article/view/3144